Adma Biologics (ADMA) EBT (QoQ) (2011 - 2025)
Adma Biologics (ADMA) EBT (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -354.78% |
| Sep 30, 2025 | 18.50% |
| Jun 30, 2025 | 19.87% |
| Mar 31, 2025 | -3.64% |
| Dec 31, 2024 | -5.54% |
| Sep 30, 2024 | 2.50% |
| Jun 30, 2024 | 94.83% |
| Mar 31, 2024 | 73.69% |
| Dec 31, 2023 | 313.02% |
| Sep 30, 2023 | 140.26% |
| Jun 30, 2023 | 6.16% |
| Mar 31, 2023 | 63.57% |
| Dec 31, 2022 | -25.16% |
| Sep 30, 2022 | -8.33% |
| Jun 30, 2022 | 24.35% |
| Mar 31, 2022 | 27.74% |
| Dec 31, 2021 | -41.81% |
| Sep 30, 2021 | 5.79% |
| Jun 30, 2021 | -2.64% |
| Mar 31, 2021 | 16.20% |